NASDAQ · Biotechnology

FENC (FENC) Stock

$10.21 +2.20% NASDAQ: FENC Healthcare

Valuation

MetricValue
Price$10.21
Market Cap$354.67M
P/E Ratio-27.42
P/B Ratio8.06
P/S Ratio5.46
EPS (TTM)$-0.36
52-Week High$11.21
52-Week Low$5.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-28.57%
ROA-14.29%
ROCE-17.14%
Gross Margin-13.33%
Operating Margin-13.33%
Net Margin-16.42%
Debt/Equity0.00
Current Ratio6.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$21.0M$48.0M$45.0M
Operating Profit$-17.0M$-22.0M$-13.0M$3.0M$-6.0M
Net Profit$-17.0M$-23.0M$-16.0M$0$-10.0M
EPS$-0.67$-0.95$-0.60$-0.02$-0.36
Op Margin—-1471.6%-60.1%5.4%-14.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$27.0M$27.0M$45.0M$70.0M
Total Liabilities$7.0M$30.0M$38.0M$51.0M$35.0M
Cash$21.0M$24.0M$13.0M$27.0M$37.0M
Borrowings$5.0M$25.0M$31.0M$19.0M$0

Latest News

Is the Options Market Predicting a Spike in Adherex Technologies Stock? Zacks · Jul 6, 2026 Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire · Jun 22, 2026 Fennec Announces Results of Annual Meeting GlobeNewswire · Jun 10, 2026 Insider Favorites High Growth Companies June 2026 Simply Wall St. · Jun 8, 2026 Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter MarketBeat · May 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-18.0M$-17.0M$27.0M$-12.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$1.0M$2.0M$-1.0M$-3.0M
Net Cash Flow$-9.0M$3.0M$-11.0M$13.0M$10.0M
Free Cash Flow$-14.0M$-18.0M$-17.0M$27.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-2.07%
Quick Ratio6.78
Interest Coverage-3.00
Return 1Y16.27%
Return 3Y25.00%
Return 5Y68.84%

Ownership

Insiders Held14.46%
Institutions Held54.31%
Institutions Float Held63.49%
Institutional HolderSharesReport Date
Rosalind Advisors, Inc.2,908,2012026-03-31
Southpoint Capital Advisors Lp2,744,7412026-03-31
Solas Capital Management, LLC2,482,1982026-03-31
AIGH Capital Management LLC1,981,5012026-03-31
Blackrock Inc.1,368,1762026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AARD $6.42 -4.04% -1.62 $140.50M 0.00%
AVTX $18.97 +2.87% -2.79 $214.25M 0.00%
BDTX $1.76 +1.45% -1.48 $100.56M 0.00%
CRBU $1.65 +0.61% -1.25 $163.65M 0.00%
ENTA $12.61 -0.94% -6.04 $366.68M 0.00%

About FENC

FENC is led by CEO Jeffrey S. Hackman, employs 32 people, headquartered in US, publicly traded since 2017.

FENC stock trades at $10.21 with a market capitalization of $354.67M. The stock is valued at a price-to-earnings (P/E) ratio of -27.42, price-to-book of 8.06, price-to-sales of 5.46. Over the past 52 weeks the stock has ranged between $5.65 and $11.21, and currently trades 8.9% below its 52-week high.

On profitability, FENC generates a return on equity (ROE) of -28.57%, return on capital employed of -17.14%, an operating margin of -13.33%, a net profit margin of -16.42%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides